Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended 31St December 2025.
11:54 AM, 12th Jan 2026
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended 31st December 2025.